欢迎来到天天文库
浏览记录
ID:53734048
大小:87.91 KB
页数:2页
时间:2020-04-20
《菌微量稀释法和纸片扩散法解释标准.pdf》由会员上传分享,免费在线阅读,更多相关内容在行业资料-天天文库。
1、Table14.Vibriospecies(NotV.cholerae)—InformationandInterpretiveCriteriaforBrothMicrodilutionandDiskDiffusionSusceptibilityTesting34Number19TestingConditionsMinimalQCRecommendationsAgentstoConsiderforPrimaryTesting®Medium:Cation-adjustedMueller-Hintonbrothformicrodilution;Esche
2、richiacoliATCC25922®Mueller-HintonagarfordiskdiffusionEscherichiacoliATCC35218(forTetracyclineInoculum:Directcolonysuspension,equivalenttoa0.5McFarlandβ-lactam/β-lactamaseinhibitorCefotaximestandard.Prepareinoculumin0.85%NaCl(normalsaline).combinations)CeftazidimeIncubation:35
3、°C;ambientair;16to20hoursFluoroquinolonesGeneralComments(1)Growthcharacteristicsonroutinemedia:halophilic;growswellonBAP;ambientair;20to24hours.Zonediameter(mm)MIC(µg/mL)CommentsAntimicrobialAntimicrobialAgentDiskInterpretiveCriteriaInterpretiveCriteriaClassDiffusionSIRSIRPENI
4、CILLINSANDβ-LACTAM/β-LACTAMASEINHIBITORCOMBINATIONSAmpicillin10µg≥1714-16≤13≤816≥32©ClinicalandLaboratoryStandardsInstitute.AllrightsreservedAmoxicillin-clavulanic20/10µg≥1814-17≤13≤8/416/8≥32/16acidAmpicillin-sulbactam10/10µg≥1512-14≤11≤8/416/8≥32/16Piperacillin100µg≥2118-20≤
5、17≤1632-64≥128Piperacillin-100/10µg≥2118-20≤17≤16/232/2-64/2≥128/2tazobactamCEPHEMSCefazolin30µg≥1815-17≤14≤816≥32Cefepime30µg≥1815-17≤14≤816≥32Cefotaxime30µg≥2315-22≤14≤816-32≥64Cefoxitin30µg≥1815-17≤14≤816≥32Ceftazidime30µg≥1815-17≤14≤816≥32Cefuroximesodium30µg≥1815-17≤14≤81
6、6≥32(parenteral)Cephalothin30µg≥1815-17≤14≤816≥32CARBAPENEMSImipenem10µg≥1614-15≤13≤48≥16Meropenem10µg≥1614-15≤13≤48≥16M45-A.©Volume26ClinicalandLaboratoryStandardsInTable14.Vibriospecies(Continued)Zonediameter(mm)MIC(µg/mL)CommentsAntimicrobialAntimicrobialAgentDiskContentInt
7、erpretiveCriteriaInterpretiveCriteriaClassSIRSIRAMINOGLYCOSIDESAmikacin30µg≥1715-16≤14≤1632≥64Gentamicin10µg≥1513-14≤12≤48≥16TETRACYCLINESTetracycline30µg≥1915-18≤14≤48≥16QUINOLONESstitute.Allrightsreserved.Ciprofloxacin5µg≥2116-20≤15≤12≥4Levofloxacin5µg≥1714-16≤13≤24≥8Ofloxac
8、in5µg≥1613-15≤12≤24≥8OTHERSChloramphenicol30µg≥1813-17≤12≤816
此文档下载收益归作者所有